Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients
Open Access
- 1 August 2004
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 66 (2), 841-848
- https://doi.org/10.1111/j.1523-1755.2004.00813.x
Abstract
No abstract availableKeywords
Funding Information
- Salt Science Research Foundation
- Ministry of Education, Culture, Sports, Science and Technology (13770602, 13877166, 14370321, 14370759, 14657618, 15790432)
This publication has 43 references indexed in Scilit:
- Iron Therapy, Advanced Oxidation Protein Products, and Carotid Artery Intima-Media Thickness in End-Stage Renal DiseaseCirculation, 2002
- Albumin is the major plasma protein target of oxidant stress in uremiaKidney International, 2001
- Importance of oxidatively modified proteins in chronic renal failureKidney International, 2001
- Importance of oxidatively modified proteins in chronic renal failureKidney International, 2001
- Beneficial effects of adopting an aggressive intravenous iron policy in a hemodialysis unitAmerican Journal of Kidney Diseases, 1999
- Influence of dialysis on plasma lipid peroxidation products and antioxidant levelsKidney International, 1996
- Reaction of Nitric Oxide with the Free Sulfhydryl Group of Human Serum Albumin Yields a Sulfenic Acid and Nitrous OxideBiochemistry, 1995
- Differential susceptibility of plasma proteins to oxidative modification: Examination by western blot immunoassayFree Radical Biology & Medicine, 1994
- Peroxynitrite‐mediated oxidation of albumin to the protein‐thiyl free radicalFEBS Letters, 1994
- Superoxide‐dependent formation of hydroxyl radicals in the presence of iron saltsFEBS Letters, 1978